𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans

✍ Scribed by S. I. VAN LEUVEN; R. S. BIRJMOHUN; R. FRANSSEN; R. J. BISOENDIAL; H. DE KORT; J. H. M. LEVELS; R. L. BASSER; J. C. M. MEIJERS; J. A. KUIVENHOVEN; J. J. KASTELEIN; E. S. STROES

Book ID
109152734
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
281 KB
Volume
7
Category
Article
ISSN
1538-7933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The kidney as a second site of human C-r
The kidney as a second site of human C-reactive protein formation in vivo
✍ Wolfram J. Jabs; Birgit A. LΓΆgering; Peter Gerke; Burkhard Kreft; Eva-Maria Wolb πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 405 KB

C-reactive protein (CRP) is the main acute phase reactant in humans. Its production is presumably restricted to the liver but extrahepatic expression by inflamed tissue has not been studied in detail. By real-time PCR and immunohistochemistry we here show that renal cortical tubular epithelial cells

Structural basis of ligand specificity i
Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component
✍ Halina Mikolajek; Simon E. Kolstoe; Valerie E. Pye; Palma Mangione; Mark B. Pepy πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 573 KB

## Abstract The normal physiological roles of the phylogenetically conserved human plasma proteins C‐reactive protein (CRP) and serum amyloid P component (SAP) are not known. Novel drugs targeting their ligand specificities are in clinical development as both proteins have significant pathophysiolo